Effective management of endocrine diseases in dogs requires more than selecting the right drug. Vets must understand the underlying pathophysiology, monitor response carefully, and adjust treatment based on both clinical signs and laboratory trends. For NAVLE® success and real-world practice, treatment decisions carry as much weight as making the diagnosis.
Treating Cushing Disease in Dogs
The primary goal in managing hyperadrenocorticism is to reduce excess cortisol and improve quality of life. Most clinicians choose medical management, especially for pituitary-dependent disease.
Trilostane serves as the first-line therapy. It inhibits an enzyme in the cortisol synthesis pathway, reducing circulating cortisol levels. This approach improves clinical signs such as polyuria, polydipsia, and polyphagia, but it does not eliminate the underlying cause.
Closely monitoring patients after initiating therapy is critical because adrenal over-suppression can lead to hypoadrenocorticism. Follow-up ACTH stimulation testing and clinical assessment are essential. Dose adjustments depend on both lab results and resolution of clinical signs.
Mitotane is an older drug that causes selective adrenal cortical necrosis. While effective, it carries a higher risk of inducing hypoadrenocorticism and has become less commonly used due to availability and safety concerns.
Beyond medications, radiation therapy or hypophysectomy can be used to reduce or eliminate pituitary tumors. Adrenalectomy is indicated for adrenal tumors. Both surgical procedures carry significant risks, requiring advanced expertise and careful perioperative management. Radiation therapy also carries risks. Only academic or specialty hospitals perform these therapies and they are often more expensive than medications.
Prognosis for pituitary-dependent disease remains good with appropriate medical therapy. Dogs often experience significant improvement in clinical signs with proper monitoring of treatment. Adrenal-dependent disease carries a fair to good prognosis following successful surgical treatment.
Image courtesy of Jen Mahon, DVM, DACVECC
Treating Hypothyroidism in Dogs
Hypothyroidism is one of the most straightforward endocrine diseases to treat. The goal is simple: replace deficient thyroid hormone and restore normal metabolic function.
Oral supplementation with levothyroxine sodium provides synthetic T4, which the body converts to active T3 as needed. Most dogs respond well, with improvements in energy levels, weight stabilization, and hair regrowth over time.
Monitor serum T4 levels after initiating therapy to ensure hormone levels rise to the upper half of the reference range. Clinical response is equally important, as normalization of behavior and coat quality confirms treatment success.
In severe cases such as myxedema coma, aggressive intervention becomes necessary. Intravenous thyroid hormone, along with supportive care including warming and fluid therapy, can be life-saving. Fortunately, this complication is rare.
Avoiding unnecessary treatment is crucial, as hypothyroidism is commonly over-diagnosed. Euthyroid sick syndrome can mimic hypothyroidism on lab work, so confirm diagnosis before initiating lifelong supplementation.
Overall, prognosis for hypothyroidism remains excellent with consistent therapy and monitoring.
Treating Diabetes Mellitus in Dogs
Diabetes mellitus requires a structured and often intensive management approach. Unlike other endocrine diseases, untreated diabetes mellitus can rapidly become life-threatening.
Insulin therapy is the foundation of treatment. Stable patients typically begin long-acting insulin on an outpatient basis, combined with a consistent feeding schedule. Establishing a routine is critical because fluctuations in feeding and insulin timing lead to poor glycemic control. Oral antihyperglycemics are more effective in cats than dogs.
Weight management plays an important supporting role. Excess adipose tissue promotes inflammation and insulin resistance, which complicates treatment. Encouraging gradual weight loss improves insulin sensitivity and overall outcomes. Exercise also improves cellular glucose uptake through non-insulin-mediated mechanisms.
Dietary adjustments may help regulate glucose absorption, but insulin remains the most important intervention. Consistency matters more than selecting a specific diet.
Image courtesy of Jen Mahon, DVM, DACVECC
Managing Diabetic Ketoacidosis (DKA)
DKA represents a medical emergency that requires immediate hospitalization. Untreated patients progress rapidly and die. These patients need:
- Intravenous fluids to correct dehydration
- Short-acting insulin to reduce hyperglycemia and ketogenesis
- Careful monitoring of electrolytes, especially potassium and phosphorus
- Treatment of comorbidities that exacerbate diabetes
Electrolyte derangements, especially hypokalemia, occur rapidly with insulin therapy, as osmotic diuresis drives urinary loss and insulin administration drives potassium intracellularly. Proactive supplementation prevents complications such as muscle weakness and cardiac arrhythmias.
Image courtesy of Jen Mahon. DVM, DACVECC
Monitoring and Long-Term Control
Successful management depends on ongoing monitoring. Clinical signs such as water intake, appetite, and body weight provide valuable information. Periodic blood glucose curves, at-home glucose monitoring, or fructosamine levels help assess long-term control.
Consistency in daily routine (i.e., feeding, insulin administration, and monitoring) remains the cornerstone of successful diabetic management.
Managing Concurrent Endocrine Disease
Dogs may present with more than one endocrine disorder, which complicates treatment decisions. A common scenario involves concurrent diabetes mellitus and Cushing disease.
In these cases, prioritize diabetes management. Uncontrolled diabetes, especially with ketoacidosis, can lead to rapid clinical deterioration and death. In contrast, Cushing disease progresses more slowly and rarely causes acute mortality.
Additionally, active illness alters cortisol levels, making diagnostic testing for Cushing disease unreliable in the presence of other diseases. Once the patient stabilizes, reassess and initiate appropriate therapy for hyperadrenocorticism if needed.
From Clinical Knowledge to NAVLE® Success
Treatment of endocrine disease requires an understanding of both pharmacology and physiology. When answering endocrine questions:
- Match treatment to the underlying mechanism of disease
- Monitor both clinical response and laboratory values
- Adjust therapy to avoid complications of overcorrection
NAVLE® questions often assess prioritization. Recognizing that a condition requires immediate intervention (especially diabetes mellitus) can guide both exam answers and clinical decision-making.
When you approach treatment with a physiology-first mindset, you build clinical confidence, improve outcomes, and develop the decision-making skills required for both the NAVLE® and everyday practice.
More from Zuku Review:
- Shop the NAVLE® Test Prep Summer Sale
- Subscribe to the Question of the Day to receive a NAVLE®-format question delivered to your inbox daily
- Review the weekly Veterinary Medicine Blog
- Earn weekly live & on-demand RACE-approved CE with ZukuCE for Vets
